Cargando…

Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection

We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine administration. The thrombocytopenia condition improved after administering steroid treatment. This adenovirus vaccine had been reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Po-Wei, Teng, Chieh-Lin Jerry, Chou, Cheng-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707922/ https://www.ncbi.nlm.nih.gov/pubmed/34960232 http://dx.doi.org/10.3390/vaccines9121486

Ejemplares similares

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
por: Bricker, Traci L., et al.
Publicado: (2021)

Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs
por: Joe, Carina C. D., et al.
Publicado: (2021)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
por: Collignon, Catherine, et al.
Publicado: (2020)

Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2023)

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
por: Hassan, Ahmed O., et al.
Publicado: (2021)

Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection
por: Lu, Mingqing, et al.
Publicado: (2023)

The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines
por: Gaunt, Eleanor R, et al.
Publicado: (2021)

Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection
por: Li, Mingxi, et al.
Publicado: (2021)

Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice
por: Lu, Mingqing, et al.
Publicado: (2022)

Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
por: Jia, Wenxu, et al.
Publicado: (2019)

Correlates of Protection Against SIV(mac251) Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
por: Tuyishime, Steven, et al.
Publicado: (2018)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013)

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
por: Warimwe, George M., et al.
Publicado: (2016)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
por: Green, C, et al.
Publicado: (2023)

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
por: He, Qian, et al.
Publicado: (2022)

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C
por: Napolitano, Federico, et al.
Publicado: (2020)

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
por: Wu, Shipo, et al.
Publicado: (2020)

Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection
por: Liu, Jiaojiao, et al.
Publicado: (2021)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
por: Zhao, Hua, et al.
Publicado: (2018)

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
por: Kennedy, Richard B
Publicado: (2022)

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C
por: Napolitano, Federico, et al.
Publicado: (2021)

Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines
por: Zhao, Mengsu, et al.
Publicado: (2023)

Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors
por: Herath, S., et al.
Publicado: (2016)

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
por: Dicks, Matthew D. J., et al.
Publicado: (2012)

Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines
por: Marcucci, Rossella, et al.
Publicado: (2021)

Lichenoid Drug Reaction Post-COVID Vaccination with the Modified Chimpanzee Adenovirus
por: García-Mendoza, Paola, et al.
Publicado: (2022)

Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
por: Xiang, Zhiquan, et al.
Publicado: (2006)

Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination
por: Haimei, MA
Publicado: (2021)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease
por: Campos, Rafael Kroon, et al.
Publicado: (2019)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults
por: Green, Christopher A., et al.
Publicado: (2019)

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
por: Herath, S., et al.
Publicado: (2015)

Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques
por: Xu, Fang, et al.
Publicado: (2022)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Berg, Adam, et al.
Publicado: (2021)

Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1
por: Patel, Shreena Umit, et al.
Publicado: (2021)

Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome
por: Gresele, Paolo, et al.
Publicado: (2021)

Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
por: Dulal, Pawan, et al.
Publicado: (2016)

Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein
por: Khan, Muhammad S, et al.
Publicado: (2022)

Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ma2en9rtsbr8tmf36q9h87f57p